Literature DB >> 2896885

Bone histology in renal transplant patients receiving cyclosporin.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2896885

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

1.  Cyclosporin A: friend or foe?

Authors:  S Epstein
Journal:  Calcif Tissue Int       Date:  1991-10       Impact factor: 4.333

2.  Effects of cyclosporins and transforming growth factor beta 1 on thyroid hormone action in cultured fetal rat limb bones.

Authors:  P Lakatos; P H Stern
Journal:  Calcif Tissue Int       Date:  1992-02       Impact factor: 4.333

3.  1,25 Dihydroxyvitamin D3 modifies cyclosporine-induced bone loss.

Authors:  S Epstein; M Schlosberg; M Fallon; S Thomas; C Movsowitz; F Ismail
Journal:  Calcif Tissue Int       Date:  1990-09       Impact factor: 4.333

Review 4.  Management of mineral and bone disorder after kidney transplantation.

Authors:  Kamyar Kalantar-Zadeh; Miklos Z Molnar; Csaba P Kovesdy; Istvan Mucsi; Suphamai Bunnapradist
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-07       Impact factor: 2.894

5.  Cyclosporines: correlation of immunosuppressive activity and inhibition of bone resorption.

Authors:  P J Stewart; P H Stern
Journal:  Calcif Tissue Int       Date:  1989-10       Impact factor: 4.333

6.  Short-term systemic insulin-like growth factor-1 is unable to prevent cyclosporin A-induced osteopenia in the rat.

Authors:  G N Mann; D A Sass; H K Chen; F J Buchinsky; H P Bryer; Y F Ma; W S Jee; B Rucinski; S Epstein
Journal:  Calcif Tissue Int       Date:  1996-07       Impact factor: 4.333

7.  Effects of cyclosporine A on chick osteoclasts in vitro.

Authors:  M H Chowdhury; V Shen; D W Dempster
Journal:  Calcif Tissue Int       Date:  1991-10       Impact factor: 4.333

8.  Acute effects of high-dose chemotherapy followed by bone marrow transplantation on serum markers of bone metabolism.

Authors:  K Carlson; B Simonsson; S Ljunghall
Journal:  Calcif Tissue Int       Date:  1994-12       Impact factor: 4.333

9.  Lack of change of cancellous bone volume with short-term use of the new immunosuppressant rapamycin in rats.

Authors:  I Joffe; I Katz; S Sehgal; F Bex; Y Kharode; J Tamasi; S Epstein
Journal:  Calcif Tissue Int       Date:  1993-07       Impact factor: 4.333

10.  Long-term therapy with cyclosporin A does not influence serum concentrations of vitamin D metabolites in patients with multiple sclerosis.

Authors:  H Reichel; A Grüssinger; A Knehans; K Kühn; H Schmidt-Gayk; E Ritz
Journal:  Clin Investig       Date:  1992-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.